血液・輸液加温システム市場　2026-2036年

「血液・輸液加温システム市場：製品、技術、用途、エンドユーザー、地域別の市場規模・シェア・動向分析 — 2036年までの世界予測」と題された最新の調査レポートによると、2025年における世界の血液・輸液加温システム市場の規模は8億5,000万米ドルでした。同市場は、2026年の推定9億1,500万米ドルから2036年には19億米ドルに達するとDataNext Researchでは予測されており、予測期間（2026年～2036年）の年平均成長率（CAGR）は7.6%となる見込みです。この市場の堅調な成長は、主に世界的な手術件数の増加と、術中・術後の偶発的な低体温症の予防に対する臨床的な関心の高まりによって牽引されています。正常体温の維持は、手術部位感染（SSI）の発生率を最大64%低減させるなど、患者の転帰を著しく改善することが臨床的に証明されています。

世界中の医療システムが患者の安全性の向上と術後合併症に伴う経済的負担の軽減に取り組む中、手術や集中治療の現場において、血液や静脈内投与液を能動的に加温するシステムの導入が標準的な医療行為（スタンダード・オブ・ケア）となっています。さらに、外傷症例の増加や救急医療サービスの拡大も市場を後押ししています。こうした現場では、患者の状態を安定させるために輸液の迅速な加温が極めて重要となるためです。

血液・輸液加温システム市場の主なハイライト

• 世界の血液・輸液加温システム市場は、2026年から2036年にかけて年平均成長率（CAGR）7.6%で推移し、2036年には19億米ドルに達すると予測されています。
• 2026年時点では、北米が世界の血液・輸液加温システム市場で最大のシェア（総収益の約40%）を占めています。これは、高い手術件数、確立された低体温症予防ガイドライン、および有利な医療費償還制度に牽引されています。
• 製品セグメント別では、血液・輸液加温システム本体が最大ですが、使い捨ての投与セットや加温用カートリッジも、安定的かつ継続的な収益源となっています。
• 用途別では手術が最大であり、次いで輸血、外傷ケア、救急・集中治療が続きます。
• エンドユーザー別では病院が最大のセグメントとして収益の大部分を占めており、外来手術センターや救急医療サービスがそれに続きます。
• 意図しない周術期低体温症の予防が市場拡大の主な要因となっており、積極的な加温を行わない場合、手術患者の最大70%が低体温症のリスクにさらされる可能性があります。
• ランセット委員会（Lancet Commission）の推定によると、世界の手術件数は年間3億1,300万件に上り、この増加傾向が加温システムの需要を拡大させています。
• 外傷ケア、軍事医療、病院前救護の現場において、携帯型やバッテリー駆動型の加温システムの利用が拡大しています。
• 乾式加温技術、スマート温度モニタリング、急速輸液プラットフォームなどが、市場を形成する主要な技術トレンドとなっています。

世界の血液・輸液加温システム市場は、製品（血液・輸液加温システム、使い捨て投与セットおよび加温カートリッジ、アクセサリー）、技術（乾式加熱、誘導加熱、向流熱交換）、用途（手術、輸血、外傷ケア、救急・集中治療）、エンドユーザー（病院、外来手術センター、救急医療サービス）、および地域別に区分されています。本調査では、業界の競合他社を対象に含めるとともに、国別の市場分析を行っています。

用途別に見ると、2026年には外科手術（サージェリー）部門が市場シェアの大部分を占めると予想されます。世界で年間3億1,300万件以上と推定される膨大な数の待機的手術および緊急手術が実施されており、これが正常体温維持に対する大規模かつ安定した需要を生み出しています。一方、最も高い成長率を示すと予測されるのは外傷ケア部門です。重度外傷症例における生存率向上への関心の高まりに加え、軍事現場や病院前救護の現場における高度な加温ソリューションの導入が進んでいることが、蘇生用専門加温システムの急速な普及を後押ししています。

エンドユーザー別では、2026年に病院部門が最大のシェアを占めると見込まれます。病院は依然として、複雑な外科手術、重度外傷の蘇生処置、大量輸血が行われる主要な現場であり、据え置き型や急速輸液用加温システムを多数必要としています。対照的に、外来手術センター（ASC）部門は、年平均成長率（CAGR）において最も高い伸びを示すと予測されています。多くの外科手術が「入院」から「外来」へと世界的に移行する中、患者の安全確保と品質基準への適合を図るため、ASCによる独自の加温インフラへの投資が進んでいます。

Report Description

According to the latest research report titled, ‘Blood and Fluid Warming Systems Market Size, Share & Trends Analysis by Product, Technology, Application, End User, and Geography—Global Forecast to 2036,’ the global blood and fluid warming systems market was valued at USD 850 million in 2025. The market is projected to reach USD 1.9 billion by 2036 from an estimated USD 915 million in 2026, growing at a CAGR of 7.6% during the forecast period (2026–2036). The steady growth of this market is primarily driven by the increasing global surgical volumes and the rising clinical emphasis on preventing inadvertent perioperative hypothermia. Maintaining normothermia has been clinically proven to significantly improve patient outcomes, including a reduction in surgical site infection (SSI) rates by as much as 64%. As healthcare systems worldwide strive to enhance patient safety and reduce the economic burden of post-operative complications, the adoption of active warming systems for blood and intravenous fluids has become a standard of care in surgical and critical care settings. The market is further supported by the growing number of trauma cases and the expansion of emergency medical services, where rapid warming of fluids is critical for patient stabilization.

The global blood and fluid warming systems market is currently navigating a profound structural transformation, a shift that is redefining the clinical standards for perioperative care and emergency resuscitation. Historically, the warming of intravenous fluids and blood products was a rudimentary process, often relying on inefficient water baths or rudimentary cabinet warmers that struggled to maintain precise temperatures during rapid administration. These legacy systems were frequently associated with risks of cross-contamination and required significant manual oversight. Today, the industry is pivoting toward ‘intelligent normothermia management,’ characterized by the integration of advanced dry-heat technology and electromagnetic induction. These modern systems provide instantaneous, precisely controlled warming that is physically integrated into high-flow rapid infusion platforms. This enables clinicians to deliver large volumes of fluids—essential in major surgeries and massive transfusions—at exact physiological temperatures, thereby virtually eliminating the risk of inadvertent perioperative hypothermia. This technological convergence is fundamentally altering the surgical workflow, making active warming an automated, low-maintenance standard rather than a specialized intervention.

Key Highlights – Blood and Fluid Warming Systems Market

• The global blood and fluid warming systems market is expected to reach USD 1.9 billion by 2036, at a CAGR of 7.6% from 2026 to 2036.
• North America accounts for the largest share of the global blood and fluid warming systems market in 2026, holding around 40% of total revenue, driven by high surgical volumes, established hypothermia prevention guidelines, and favorable reimbursement.
• Blood and fluid warming systems represent the largest product segment, while disposable administration sets and warming cartridges provide a substantial and recurring revenue stream.
• Surgery is the largest application, followed by blood transfusion, trauma care, and emergency and critical care.
• Hospitals are the largest end-user segment, accounting for the majority of revenue, followed by ambulatory surgery centres and emergency medical services.
• The prevention of inadvertent perioperative hypothermia is a primary driver, with up to 70% of surgical patients at risk of hypothermia without active warming.
• Rising global surgical volumes, estimated by the Lancet Commission at 313 million procedures per year, are expanding demand for warming systems.
• Portable and battery-powered warming systems are expanding use in trauma, military, and prehospital settings.
• Dry heat technology, smart temperature monitoring, and rapid infusion platforms are among the key technology trends shaping the market.

Another pivotal dimension of this transformation is the ‘portability revolution’ that is extending the reach of active warming far beyond the sterile confines of the operating room. The market is witnessing a surge in the development of lightweight, battery-powered, and ruggedized warming systems designed specifically for prehospital, military, and aeromedical transport settings. These devices allow for the initiation of warming protocols at the point of injury, which is critical for disrupting the ‘lethal triad’ of trauma—the synergistic progression of hypothermia, acidosis, and coagulopathy that often leads to irreversible physiological decline. By enabling normothermic resuscitation in the field, these portable solutions are significantly improving survival rates for trauma patients during the ‘golden hour’ of care. Furthermore, the industry is undergoing a transition in its economic structure, where the recurring revenue from high-performance disposable administration sets and warming cartridges is becoming the primary engine of market growth. This shift toward a ‘disposable-centric’ model is driving intense innovation in material science, as manufacturers seek to develop disposables that offer superior heat transfer efficiency, lower flow resistance, and integrated air-elimination features. The incorporation of smart connectivity and IoT (Internet of Things) capabilities is also becoming a standard requirement, allowing for the automated capture of temperature data into Electronic Health Records (EHRs), which enhances clinical documentation and supports hospital-wide quality improvement initiatives.

Market Segmentation Analysis

The global blood and fluid warming systems market is segmented by product (blood and fluid warming systems, disposable administration sets and warming cartridges, and accessories), technology (dry heat, induction, and countercurrent heat exchange), application (surgery, blood transfusion, trauma care, and emergency and critical care), end user (hospitals, ambulatory surgery centres, and emergency medical services), and geography. The study evaluation includes industry competitors and analyzes the market at the country level.

Based on Product

By product, the blood and fluid warming systems segment is expected to hold the largest share of the market in 2026. This segment includes stationary, portable, and rapid infusion devices that serve as the capital equipment foundation for warming protocols in hospitals and clinics. The high unit cost of advanced rapid infusion systems and the increasing adoption of portable units in emergency services drive this segment’s dominance. However, the disposable administration sets and warming cartridges segment is projected to register the highest CAGR during the forecast period. The growth of this segment is fueled by the high-volume, recurring demand for sterile disposables required for every patient procedure, combined with the rising number of surgical and transfusion cases globally.

Based on Technology

By technology, the dry heat segment is expected to hold the largest share in 2026. Dry heat warming has become the preferred choice for most clinical settings due to its safety profile, as it eliminates the infection risks associated with water-based systems. It also offers faster warm-up times and easier maintenance. Meanwhile, the induction warming segment is projected to grow at the fastest CAGR. Induction technology allows for extremely rapid and efficient heating of fluids directly within the administration set, making it ideal for high-flow resuscitation and massive transfusion scenarios where time is of the essence.

Based on Application

By application, the surgery segment is expected to be the major contributor to the market share in 2026. The vast number of elective and emergency surgical procedures performed annually—estimated at over 313 million worldwide—creates a massive and consistent demand for normothermia maintenance. However, the trauma care segment is projected to witness the fastest growth. The increasing focus on improving survival rates in severe trauma cases, combined with the deployment of advanced warming solutions in military and prehospital settings, is driving the rapid adoption of specialized warming systems for resuscitation.

Based on End User

By end user, the hospitals segment is expected to hold the largest share in 2026. Hospitals remain the primary setting for complex surgeries, major trauma resuscitation, and large-volume blood transfusions, requiring a significant fleet of stationary and rapid infusion warming systems. Conversely, the ambulatory surgery centres (ASCs) segment is projected to grow at the fastest CAGR. The global shift of many surgical procedures from inpatient to outpatient settings is driving ASCs to invest in their own warming infrastructure to ensure patient safety and comply with quality standards.

Geographic Analysis

In 2026, North America is expected to account for the largest share of the global blood and fluid warming systems market, representing a dominant 40% of the total global revenue. The region’s commanding position is anchored by a unique combination of high clinical standards, robust healthcare spending, and a well-established regulatory framework that prioritizes patient safety. The United States, in particular, is the primary driver of this regional market, featuring a vast network of tertiary-care hospitals and specialized surgical centres that perform a high volume of complex procedures requiring active warming. The adoption of warming systems in North America has been accelerated by the widespread implementation of clinical guidelines from prestigious organizations such as the American Society of Anesthesiologists (ASA) and the Association of periOperative Registered Nurses (AORN). These guidelines have effectively transformed normothermia maintenance from a recommended practice into a core quality metric that directly impacts hospital accreditation and reimbursement. Furthermore, the region is a hub for medical technology innovation, home to several of the world’s leading manufacturers of warming solutions. The presence of these companies facilitates rapid market penetration of new technologies, such as rapid infusion platforms and smart warming disposables. The North American market is also characterized by significant investment in military and emergency medical services, where there is a high demand for ruggedized, portable warming systems for use in challenging field environments. The key companies operating in the North American market include 3M Company, Becton, Dickinson and Company (BD), Belmont Medical Technologies, Stryker Corporation, and GE HealthCare.

Europe represents a substantial and highly sophisticated segment of the global blood and fluid warming systems market, accounting for approximately 28% of global revenue in 2026. The region’s market dynamics are characterized by a strong emphasis on evidence-based clinical practices and a highly coordinated approach to patient safety. European nations, particularly Germany, the United Kingdom, and France, have been at the forefront of developing and implementing rigorous perioperative care bundles. The UK’s National Institute for Health and Care Excellence (NICE) guidelines on the management of inadvertent perioperative hypothermia in adults have served as a global benchmark, driving the widespread adoption of active warming technologies across the continent. The European market is also distinguished by its leadership in specialized warming applications, such as neonatology and high-precision critical care, where maintaining thermal stability is paramount for vulnerable patient populations. Furthermore, the region’s robust public healthcare systems and universal coverage models support a steady demand for high-quality medical devices, although cost-containment measures drive a strong focus on demonstrating the economic value of warming solutions in reducing post-operative complications and length of stay. The presence of numerous innovative mid-sized manufacturers in Germany and the Netherlands fosters a highly competitive environment that drives continuous improvement in device safety and performance. The key companies operating in the European market include Smiths Medical (ICU Medical), Barkey GmbH & Co. KG, Stihler Electronic GmbH, The Surgical Company (TSC), and Vyaire Medical.

Asia-Pacific is projected to be the most dynamic and fastest-growing region in the global blood and fluid warming systems market, registering the highest CAGR during the forecast period. This rapid expansion is primarily driven by the massive investments in healthcare infrastructure currently underway in China, India, and Southeast Asia. As these nations seek to modernize their hospital networks and expand surgical capacity to meet the needs of their growing populations, there is a surge in demand for essential medical equipment, including advanced warming systems. The transition from basic care to high-standard surgical services is a key driver, as healthcare providers increasingly adopt international best practices for hypothermia prevention to improve clinical outcomes and reduce the incidence of surgical site infections. In China, government-led initiatives to improve medical device accessibility and quality are fostering a highly receptive market for both global and domestic manufacturers. In India, the expansion of the private hospital sector and the rising prevalence of medical insurance are enabling more patients to access sophisticated surgical procedures that utilize active warming. The region’s growth is further bolstered by the burgeoning medical tourism industry in countries like Thailand, Malaysia, and South Korea, where hospitals are investing in cutting-edge technologies to compete on the global stage for international patients. As awareness of the clinical and economic benefits of normothermia continues to rise among clinicians and hospital administrators, the Asia-Pacific market is expected to remain a primary growth engine for the global industry. The key companies operating in the Asia-Pacific market include global leaders through their extensive regional distribution networks and a growing number of emerging local manufacturers such as Keewell Medical Technology.

Latin America and the Middle East & Africa (MEA) represent critical emerging frontiers for the blood and fluid warming systems market, where the demand for advanced medical technologies is rising in tandem with healthcare modernization efforts. In Latin America, the market is primarily driven by the expansion of surgical services and the implementation of improved clinical standards in major economies such as Brazil, Mexico, and Colombia. There is a particularly strong focus on improving maternal and neonatal health outcomes, where maintaining thermal stability is essential, driving the adoption of specialized fluid warming for high-risk deliveries and neonatal care. In the Middle East, the market is propelled by ambitious government-led development plans, such as Saudi Arabia’s ‘Vision 2030,’ which include massive investments in state-of-the-art ‘health cities’ and specialized trauma centres. These nations are early adopters of premium medical solutions, including high-flow rapid infusion platforms and smart, connected warming systems, as they strive to build world-class healthcare infrastructures. The GCC countries, in particular, represent a high-value segment due to their high per-capita healthcare spending and preference for advanced, integrated technologies. In Africa, the market is in the early stages of development but presents significant long-term potential. Growth is currently concentrated in major urban centres where international aid and government initiatives are focused on enhancing emergency medical services and basic surgical capacity. As these regions continue to invest in their healthcare systems and improve patient access to advanced care, the demand for reliable and easy-to-use blood and fluid warming solutions is expected to grow steadily. The key companies operating in these regions include global manufacturers who partner with specialized local distributors to provide the necessary technical expertise and clinical training to local healthcare providers.

Competitive Landscape

The global blood and fluid warming systems market is competitive and moderately consolidated, with a mix of large medical device companies and specialized warming device manufacturers. Competition spans established providers of hospital warming and rapid infusion systems, specialized portable and prehospital warming companies, and regional manufacturers. Participants compete on warming performance and flow rates, portability, safety and ease of use, disposable design and cost, clinical evidence, and breadth of product portfolio across applications and settings. Leading companies offer both capital equipment and disposables, and compete across surgery, transfusion, trauma, and emergency applications.

A key competitive trend is the development of portable, battery-powered, and dry-heat warming systems for trauma, prehospital, and military use, alongside advanced rapid infusion platforms for major surgery and trauma. Companies are investing in portability, smart temperature monitoring, and disposable design, while specialized firms compete strongly in prehospital and military warming. Partnerships, product development, and the expansion of disposable and consumable offerings are shaping the market, and the emphasis on clinical outcomes, portability, and total cost is favoring companies that can deliver effective, safe, and cost-justified warming across care settings.

Key Players

The key players operating in the global blood and fluid warming systems market include 3M Company (U.S.), Becton, Dickinson and Company (BD) (U.S.), Smiths Medical (ICU Medical) (U.S.), Belmont Medical Technologies (U.S.), Stryker Corporation (U.S.), GE HealthCare (U.S.), Boston Scientific Corporation (U.S.), Barkey GmbH & Co. KG (Germany), Stihler Electronic GmbH (Germany), The Surgical Company (TSC) (Netherlands), MEQU (Denmark), QinFlow (Quality in Flow) (Israel), EMIT Corporation (U.S.), Smisson-Cartledge Biomedical (SCB) (U.S.), Keewell Medical Technology (China), Inspiration Healthcare Group (Inditherm) (U.K.), Gentherm (U.S.), and Enthermics Medical Systems (U.S.).

Key Questions Answered in the Report—

• What is the projected size of the global blood and fluid warming systems market by 2036?

The global blood and fluid warming systems market is projected to reach USD 1.9 billion by 2036.

• What is the expected CAGR for the market during the forecast period?

The market is expected to grow at a CAGR of 7.6% from 2026 to 2036.

• Which product segment is expected to hold the major share of the market in 2026?

The blood and fluid warming systems segment is expected to hold the largest share due to the high cost of capital equipment.

• Which geographical region is expected to dominate the market in 2026?

North America is expected to dominate the market with a 40% share, driven by advanced infrastructure and established guidelines.

• How does normothermia maintenance impact surgical site infection (SSI) rates?

Maintaining normothermia has been shown to reduce SSI rates by up to 64%, improving patient outcomes and reducing hospital stays.

• What are the primary advantages of dry heat technology over water-based systems?

Dry heat systems offer faster warming, easier maintenance, and significantly lower risks of bacterial contamination.

• Which application segment is expected to witness the fastest growth during the forecast period?

The trauma care segment is projected to grow the fastest, driven by the adoption of portable warming in prehospital and military resuscitation.

• What is the role of disposable administration sets in the market’s revenue structure?

Disposables provide a substantial and recurring revenue stream, growing at a higher CAGR than capital equipment as surgical volumes rise.

Scope of the Report:

Blood and Fluid Warming Systems Market Assessment — by Product

• Blood and Fluid Warming Systems (Stationary, Portable, Rapid Infusion)
• Disposable Administration Sets and Warming Cartridges
• Accessories

Blood and Fluid Warming Systems Market Assessment — by Technology

• Dry Heat
• Induction
• Countercurrent Heat Exchange

Blood and Fluid Warming Systems Market Assessment — by Application

• Surgery
• Blood Transfusion
• Trauma Care
• Emergency and Critical Care
• Other Applications

Blood and Fluid Warming Systems Market Assessment — by End User

• Hospitals
• Ambulatory Surgery Centres (ASCs)
• Emergency Medical Services (EMS)
• Other End Users

Blood and Fluid Warming Systems Market Assessment — by Geography

• North America (U.S., Canada)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Australia, Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)

Table of Contents

1. Introduction

1.1. Market Definition

1.2. Market Ecosystem

1.3. Currency and Limitations

1.3.1. Currency

1.3.2. Limitations

1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach

2.2. Data Collection & Validation

2.2.1. Secondary Research

2.2.2. Primary Research

2.3. Market Assessment

2.3.1. Market Size Estimation

2.3.2. Bottom-Up Approach

2.3.3. Top-Down Approach

2.3.4. Growth Forecast

2.4. Assumptions for the Study

3. Executive Summary

3.1. Overview

3.2. Market Analysis, by Product

3.3. Market Analysis, by Technology

3.4. Market Analysis, by Application

3.5. Market Analysis, by End User

3.6. Market Analysis, by Geography

3.7. Adoption Analysis

3.8. Competitive Analysis

4. Market Insights

4.1. Introduction

4.2. Global Blood and Fluid Warming Systems Market: Impact Analysis of Market Drivers (2026–2036)

4.2.1. Rising Surgical Procedures Worldwide

4.2.2. Increasing Blood Transfusions and Intravenous Fluid Administration

4.2.3. Growing Trauma and Emergency Care Cases

4.2.4. Increasing Awareness of Perioperative Hypothermia Prevention

4.3. Global Blood and Fluid Warming Systems Market: Impact Analysis of Market Restraints (2026–2036)

4.3.1. High Cost of Blood and Fluid Warming Systems

4.3.2. Limited Adoption in Cost-Sensitive Healthcare Settings

4.4. Global Blood and Fluid Warming Systems Market: Impact Analysis of Market Opportunities (2026–2036)

4.4.1. Growing Adoption in Ambulatory Surgery Centres

4.4.2. Expanding Military and Prehospital Applications

4.4.3. Increasing Healthcare Investments in Emerging Markets

4.5. Global Blood and Fluid Warming Systems Market: Impact Analysis of Market Challenges (2026–2036)

4.5.1. Regulatory Compliance

4.5.2. Clinical Evidence and Cost Justification

4.6. Global Blood and Fluid Warming Systems Market: Impact Analysis of Market Trends (2026–2036)

4.6.1. Portable and Battery-Powered Warming Systems

4.6.2. Dry Heat Technologies

4.6.3. Smart Temperature Monitoring

4.6.4. Expansion of Rapid Infusion Platforms

4.7. Market Adoption Analysis

4.7.1. Adoption by Product

4.7.2. Adoption by Technology

4.7.3. Adoption by Application

4.7.4. Adoption by End User

4.7.5. Adoption by Geography

4.8. Porter’s Five Forces Analysis

5. Industry Ecosystem / Value Chain

5.1. Introduction to the Blood and Fluid Warming Systems Value Chain

5.2. Component Suppliers

5.3. Blood and Fluid Warming System Manufacturers

5.4. Disposable Set & Consumable Manufacturers

5.5. Distribution Partners

5.6. Hospitals and Other End Users

6. Competitive Landscape

6.1. Introduction

6.2. Key Growth Strategies

6.3. Competitive Dashboard

6.4. Vendor Market Positioning

6.5. Global Market Share / Ranking Analysis

6.6. Regional Market Share Analysis

6.7. Product Portfolio Benchmarking

6.8. Technology Benchmarking

6.9. Competitive Developments

7. Blood and Fluid Warming Systems Market, by Product Category

7.1. Introduction

7.2. Blood and Fluid Warming Systems

7.2.1. Portable Systems

7.2.2. Stationary Systems

7.3. Rapid Infusion Systems

7.4. Disposable Administration Sets & Warming Cartridges

7.5. Accessories

8. Blood and Fluid Warming Systems Market, by Heating Technology

8.1. Introduction

8.2. Dry Heat Technology

8.3. Induction Heating Technology

8.4. Countercurrent Heat Exchange Technology

8.5. Other Technologies

9. Blood and Fluid Warming Systems Market, by Application

9.1. Introduction

9.2. Blood Transfusion

9.3. Intravenous Fluid Administration

9.4. Medication Infusion

9.5. Surgery

9.6. Trauma Care

9.7. Emergency Care

9.8. Critical Care

9.9. Military & Prehospital Care

9.10. Other Applications

10. Blood and Fluid Warming Systems Market, by End User

10.1. Introduction

10.2. Hospitals

10.3. Ambulatory Surgery Centres

10.4. Blood Banks

10.5. Emergency Medical Services

10.6. Military Healthcare Facilities

10.7. Specialty Clinics

10.8. Other End Users

11. Blood and Fluid Warming Systems Market, by Geography

11.1. Introduction

11.2. North America

11.2.1. United States

11.2.2. Canada

11.3. Europe

11.3.1. Germany

11.3.2. United Kingdom

11.3.3. France

11.3.4. Italy

11.3.5. Spain

11.3.6. Rest of Europe

11.4. Asia-Pacific

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. South Korea

11.4.6. Rest of Asia-Pacific

11.5. Latin America

11.5.1. Brazil

11.5.2. Mexico

11.5.3. Rest of Latin America

11.6. Middle East & Africa

11.6.1. GCC Countries

11.6.2. South Africa

11.6.3. Rest of Middle East & Africa

12. Company Profiles

(Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

12.1. ICU Medical, Inc.

12.2. Belmont Medical Technologies

12.3. 3M Company (Ranger Blood & Fluid Warming Systems)

12.4. Barkey GmbH & Co. KG

12.5. Biegler GmbH

12.6. QinFlow Ltd.

12.7. The 37Company B.V.

12.8. MEQU A/S

12.9. Geratherm Medical AG

12.10. Estill Medical Technologies, Inc.

12.11. EMIT Corporation

12.12. Keewell Medical Technology Co., Ltd.

12.13. Shenzhen Comen Medical Instruments Co., Ltd.

12.14. North American Rescue, LLC

12.15. Other Players

13. Sustainability Impact Analysis

13.1. Improving Patient Safety and Clinical Outcomes

13.2. Reducing Blood and Fluid Wastage

13.3. Supporting Sustainable Healthcare Delivery

13.4. Improving Resource Utilisation in Acute Care

14. Appendix

14.1. Questionnaire

14.2. Available Customization

---

---